Omega Flex, Inc. (OFLX)
NASDAQIndustrialsIndustrial - MachinerySnapshot 2026-09-04
$26.91+2.71%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsIndustrial - MachinerySnapshot 2026-09-04
QuarterlyIQ Insights · OFLX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -10.4% |
| Our one-year growth estimate | diamond | -6.3% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 4.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 64 industry peers · Company calendar date is not available
OFLX — legal / regulatory event — CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT The
Dated 2026-06-15
CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT The Audit Committee of the Board of Directors of Omega Flex, Inc. (the “Company”) conducted a comprehensive process to determine the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, and issued a Request for Proposal (“RFP”) to several qualified accounting firms, including RSM US LLP (“RSM”), the Company’s then current independent registered public accounting firm. As a result of this process, fo…
Why it matters: Higher margins show better cost management. This may help the company make more money.
Supportive ifGross margins improve to above 30% in Q3.
Worry ifGross margins remain below 30% in Q3.
Why it matters: Sales growth from MediTrac could signal successful market expansion. This may improve overall revenue.
Supportive ifMediTrac will see a big rise in sales next quarter.
Worry ifMediTrac sales do not grow or decline in the next quarter.
Why it matters: Rising costs could further squeeze profits and impact future pricing strategies.
Worry ifNet income decreases more than 35% year over year due to rising raw material costs.
Less concerning ifNet income stays the same or grows each year, even with rising raw material costs.
Why it matters: Entering the European market could increase sales. It would also show that product development is working.
Supportive ifA press release that confirms early sales or partnerships for MediTrac in Europe.
Worry ifNo updates or news on MediTrac sales or partnerships in Europe within the next six months.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$123 on $10,000 · ±1.2% | How much price usually moves either way. |
| Bad day | $362 loss on $10,000 · 3.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,009 loss on $10,000 · 30.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Changing the accounting firm can impact financial reporting and investor confidence. It is a key governance issue.
Worry ifThe company picks a new accounting firm after the RFP process.
Less concerning ifThe company keeps its current accounting firm without changes.
Why it matters: A big drop in net sales would show worse market conditions and demand problems.
Worry ifQ3 net sales down year over year worse than -5.8%.
Less concerning ifQ3 net sales stabilize or grow year over year.
Why it matters: Sales from MediTrac will show if the CE mark approval translates to market demand.
Supportive ifMediTrac sales exceed $1 million in Q3.
Worry ifMediTrac sales fall below $500,000 in Q3.
Why it matters: Investments in capacity and efficiency are key for future growth. Progress here could boost financial performance.
Supportive ifManagement says key investments are done. These investments help operations run better.
Worry ifThere are no updates on investments or project delays. This may show operational issues.
Why it matters: Rising raw material costs have hurt profits. Keeping an eye on these costs will help assess future profits.
Worry ifRaw material costs stabilize or drop. This leads to better profit margins.
Less concerning ifRaw material costs rise again. This worsens profit margins and net income.
Why it matters: Improvement in sector growth could benefit Omega Flex's performance. The sector is currently in a maturing phase.
Supportive ifSector revenue growth speeds up again, showing a positive trend.
Worry ifSector revenue growth slows down, showing ongoing challenges.
Why it matters: Changing the accounting firm can affect investor trust and financial reporting quality. It is a sign of internal governance.
Worry ifThe company has a new accounting firm that is independent and public.
Less concerning ifThe company retains the current accounting firm, RSM US LLP, for the fiscal year.
Why it matters: Earnings will show if sales and profits continue to decline. This impacts future growth plans.
Worry ifQ2 2026 earnings report shows net income decreases more than 41.8% year over year.
Less concerning ifNet income stays the same or goes up compared to Q2 2025.
Why it matters: Changes in the accounting firm can affect how investors feel and how finances are reported.
Worry ifA press release confirms a new independent accounting firm.
Less concerning ifNo changes were announced. The current accounting firm stays.
Why it matters: Changes in the dividend could signal financial health. A cut might worry investors about cash flow.
Watch forThe Board maintains the quarterly dividend at $0.34 per share.
Also watch forThe Board reduces the quarterly dividend below $0.34 per share.
Why it matters: Strong sales growth for MediTrac CMT could help offset drops in other products.
Supportive ifMediTrac CMT sales grow more than 10% quarter over quarter.
Worry ifMediTrac CMT sales decline or remain flat quarter over quarter.
Why it matters: A change in the dividend could show financial trouble or a shift in spending.
Watch forThe company maintains the quarterly dividend at $0.34 per share.
Also watch forThe company cuts the quarterly dividend below $0.34 per share.